SL4

Researchers from Tel Aviv University, the Technion, and Cornell wrapped antibodies in temporary chemical “camouflage” and packaged them in lipid nanoparticles. In a preclinical model, the antibodies were able to reach nerve cells and reduce alpha-synuclein aggregates—but